Appeals court revives lawsuits claiming link between acetaminophen, ADHD and autism

Appeals court revives lawsuits claiming link - Thinking Process: 1. **Analyze the Request:** * **Role:** Professional editor. * **Task:** Rewrite an article into a new, unique version with proper HTML formatting. * **Source URL:** https://thehill.com/regulation/court-battles/5966527-acetaminophen-autism-adhd-lawsuit/ * **Original Title:** Appeals court revives lawsuits claiming link between acetaminophen, ADHD and autism * **Original Content:** Provided text about a federal appeals court (2nd Circuit) reviving lawsuits regarding acetaminophen (Tylenol) and neurodevelopmental disorders (autism, ADHD). Key details: Kenvue, Walgreens, CVS, Walmart, Target as defendants; Judge Guido Calabresi's ruling; expert testimony; Kenvue's denial and stock drop; Trump/Kennedy Jr. warnings; FDA label update. * **Rules:** * Language: English. * Preserve factual accuracy. * No verbatim copying; avoid long phrases (no 8+ consecutive words). * Change structure: reorder paragraphs, vary wording. * Preserve direct quotes using `

`. * Use clean structure with `

`, `

`, and `

`. * Produce ONLY the rewritten HTML (no markdown, no commentary). * **Minimum length: 600 words.** (Crucial constraint: Source text is ~350 words. I need to expand naturally without adding false info). 2. **Fact Extraction & Verification:** * Court: 2nd U.S. Circuit Court of Appeals. * Action: Revived hundreds of lawsuits. * Claim: Link between acetaminophen and neurodevelopmental disorders (autism, ADHD). * Reason: Lower court improperly threw out expert testimony. * Defendants: Pharmacies (Walgreens, CVS, Walmart, Target) and Kenvue (Tylenol manufacturer). * Judge: Guido Calabresi (Clinton appointee). * Quote 1 (Calabresi): “Those concededly qualified experts offered opinions that comport with 17 methodologies applied by other scientists in their fields, and constitute acceptable 18 interpretations of scientific evidence where scientists may, and in fact do, disagree 19 on the ultimate answer to the causal question that they are assessing,” * Note on Quote: The numbers 17, 18, 19 seem to be footnote markers in the original. I should keep the text but maybe clean up the numbers or keep them as is if they are part of the quote. Looking closely at the source text provided: "comport with 17 methodologies... acceptable 18 interpretations... disagree 19 on". I will keep the numbers to be safe, or remove them if they look like artifacts. Usually, in these tasks, keeping the exact quote is safer. I'll keep the numbers as they appear in the provided text snippet. * Ruling Scope: Expert testimony admissibility, not final proof of link. * Kenvue/ACOG Stance: Deny link. * Stock Impact: Fell 1.35% Monday evening. * Kenvue Statement: "The procedural ruling today does not change the fact that credible, independent science shows no proven link between taking acetaminophen and autism or attention deficit hyperactivity disorder (ADHD). Science matters, and we stand with the many public health and medical professionals who have reviewed the science on this topic and agree," * Kenvue Statement (continued): “We now have another opportunity to show that the plaintiffs’ experts’ opinions are unreliable and should not be allowed. We are exploring all options regarding this decision. We stand behind the safety of our product and will continue to defend these cases,” * Context: President Trump and HHS Secretary Robert F. Kennedy Jr. warned pregnant women last year. * Kennedy/FDA: FDA updating label, notifying physicians Tylenol "can be associated with a very increased risk of autism." 3. **Expansion Strategy (to reach 600 words):** * Elaborate on the significance of the 2nd Circuit's decision. * Explain the role of expert testimony in legal proceedings more fully. * Discuss the background of the lawsuits (hundreds of them). * Detail the defendants' positions. * Expand on the political context (Trump/Kennedy Jr.) and its impact on public perception. * Describe the potential implications for future litigation. * Ensure no new facts are invented (e.g., don't say "millions of dollars" unless implied or general knowledge, but better to stick to "shares fell"). * Use transitional phrases to connect ideas smoothly. * Break down the quotes into analysis. 4. **Drafting - Section by Section (Mental Outline):** * **Headline:** Needs to be catchy and accurate. * **Introduction:** Summarize the main event (court revival) and the core issue (acetaminophen/neurodevelopmental link). * **The Court's Decision:** Focus on Judge Calabresi's reasoning regarding expert witnesses. * **The Parties Involved:** List the pharmacies and Kenvue. * **Kenvue's Response:** Stock drop, statement, defense strategy. * **Broader Context:** Political warnings (Trump/Kennedy), FDA actions. * **Conclusion:** What this means moving forward. 5. **Writing & Checking Constraints:** * *Constraint Check:* No 8+ consecutive words from original. * *Constraint Check:* HTML tags only. * *Constraint Check:* Min 600 words. *Drafting content:* (Need to ensure I don't just summarize but expand on the implications and details provided.) *Paragraph 1:* A significant legal development occurred on Monday when a federal appellate court determined that numerous legal actions concerning acetaminophen should proceed. These cases allege that exposure to the common pain reliever during pregnancy contributes to neurodevelopmental conditions in children. Specifically, the 2nd U.S. Circuit Court of Appeals ruled that a previous dismissal was premature because it excluded crucial scientific testimony. *Paragraph 2:* The appellate judges found fault with the lower court’s handling of expert witnesses. These specialists provided data suggesting a connection between the medication and various pregnancy-related complications. By allowing this testimony back into the mix, the higher court opened the door for plaintiffs to present their arguments more effectively. *Paragraph 3:* The scope of the litigation is broad, involving major retail entities alongside the pharmaceutical producer. Kenvue, which produces Tylenol, faces allegations alongside prominent pharmacy chains such as Walgreens, CVS, Walmart, and Target. This collective group of defendants must now navigate the renewed legal challenges. *Paragraph 4:* Judge Guido Calabresi, a nominee appointed by President Clinton, authored the extensive 64-page opinion. He emphasized the validity of the scientific opinions presented. In his written assessment, he noted that the experts utilized recognized methods consistent with their peers. *Quote insertion:*

“Those concededly qualified experts offered opinions that comport with 17 methodologies applied by other scientists in their fields, and constitute acceptable 18 interpretations of scientific evidence where scientists may, and in fact do, disagree 19 on the ultimate answer to the causal question that they are assessing,”

*Paragraph 5:* It is important to clarify that this specific ruling addresses the admissibility of evidence rather than establishing a definitive causal relationship. Calabresi made it clear that the decision does not confirm whether acetaminophen causes autism or attention deficit hyperactivity disorder (ADHD). Instead, it ensures that the scientific debate can be heard within the courtroom setting. *Paragraph 6:* Kenvue and the American College of Obstetricians and Gynecologists have consistently maintained that there is no established connection between the over-the-counter drug and developmental issues. They argue that the medication remains safe for use during pregnancy to manage fever and pain. Despite this stance, the market reacted negatively to the news. *Paragraph 7:* Financial markets responded swiftly to the court's announcement. By the close of trading on Monday, Kenvue’s stock price decreased by 1.35 percent. Investors appear concerned about the potential financial exposure resulting from the revived lawsuits. *Paragraph 8:* In response to the developments, Kenvue issued a formal statement emphasizing their confidence in existing scientific data. They reiterated that independent research has not yet proven a direct link to autism or ADHD. The company expressed solidarity with medical professionals who support the current understanding of the drug's safety profile. *Quote insertion:*

“The procedural ruling today does not change the fact that credible, independent science shows no proven link between taking acetaminophen and autism or attention deficit hyperactivity disorder (ADHD). Science matters, and we stand with the many public health and medical professionals who have reviewed the science on this topic and agree,”

*Paragraph 9:* Furthermore, the corporation indicated that it would vigorously challenge the reliability of the plaintiffs' witnesses. Management stated they are reviewing all available avenues to address the court's decision. They pledged to continue defending the product's reputation and safety record in court. *Paragraph 10:* This legal shift comes shortly after high-profile political commentary regarding acetaminophen usage. Last year, President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. both advised expectant mothers to exercise caution. Their warnings contributed to heightened public awareness of the potential risks. *Paragraph 11:* Secretary Kennedy specifically mentioned that regulatory bodies were taking steps to address these concerns. He noted that the Food and Drug Administration (FDA) plans to revise the product labeling. Additionally, healthcare providers are being informed that Tylenol may carry a heightened risk for autism. *Paragraph 12:* As the lawsuits move forward, the interplay between scientific evidence and legal standards will remain central. The appellate court’s decision allows the debate to continue, giving both sides a chance to present their case fully. For Kenvue and the pharmacies involved, the coming months will likely involve intense scrutiny of expert opinions and medical data. *Word Count Check:* Let's estimate. P1: ~70 P2: ~60 P3: ~60 P4: ~60 Quote: ~80 P5: ~70 P6: ~70 P7: ~60 P8: ~80 Quote: ~90 P9: ~70 P10: ~70 P11: ~70 P12: ~70 Total approx: 950 words. This is well over 600. *Refining for "No 8+ consecutive words":* I need to check my draft against the original text to ensure I haven't accidentally copied long phrases. Original: "A federal appeals court on Monday revived hundreds of lawsuits where plaintiffs claimed to have evidence of a link between acetaminophen and neurodevelopmental disorders." My P1: "A significant legal development occurred on Monday when a federal appellate court determined that numerous legal actions concerning acetaminophen should proceed." (Safe) Original: "The 2nd U.S. Circuit Court of Appeals said a lower court improperly threw out testimony from scientific experts that provided evidence of a link between the pain killer and pregnancy related issues." My P2: "The appellate judges found fault with the lower court’s handling of expert witnesses." (Safe) Original: "Pharmacies including Walgreens, CVS, Walmart and Target were named as defendants in addition to Kenvue, the manufacturer of Tylenol." My P3: "Kenvue, which produces Tylenol, faces allegations alongside prominent pharmacy chains such as Walgreens, CVS, Walmart, and Target." (Safe) Original: "“Those concededly qualified experts offered opinions that comport with 17 methodologies applied by other scientists in their fields, and constitute acceptable 18 interpretations of scientific evidence where scientists may, and in fact do, disagree 19 on the ultimate answer to the causal question that they are assessing,” Circuit Judge Guido Calabresi, a Clinton appointee, wrote in the 64-page ruling ." My Quote: Kept exact. Original: "Calabresi said the ruling regarding the expert testimony had no bearing over whether there was a link between acetaminophen and autism or attention deficit hyperactivity disorder (ADHD)." My P5: "It is important to clarify that this specific ruling addresses the admissibility of evidence rather than establishing a definitive causal relationship." (Safe) Original: "Kenvue and the American College of Obstetricians and Gynecologists have repeatedly denied the link between neurodevelopmental disorders and the use of the over-the-counter medication during pregnancy to combat fevers or pain." My P6: "Kenvue and the American College of Obstetricians and Gynecologists have consistently maintained that there is no established connection between the over-the-counter drug and developmental issues." (Safe) Original: "The company’s shares fell by 1.35 percent as of Monday evening." My P7: "Financial markets responded swiftly to the court's announcement. By the close of trading on Monday, Kenvue’s stock price decreased by 1.35 percent." (Safe) Original: "“The procedural ruling today does not change the fact that credible, independent science shows no proven link between taking acetaminophen and autism or attention deficit hyperactivity disorder (ADHD). Science matters